Ventana Medical Systems
Nataliya Means is an experienced regulatory affairs manager with a strong background in quality assurance and microbiology. At Ventana Medical Systems since November 2008, Nataliya has managed regulatory approval processes for in vitro diagnostic medical devices and collaborated with various departments and international affiliates for product registrations. Prior roles include serving as a microbiologist at Erlan Corporation, where oversight of quality control for beverages was conducted, and as a bacteriologist at the Central Water Plant, responsible for ensuring quality control of treated wastewater. Educational qualifications include a Bachelor's degree in Microbiology and a Graduate Research Associate degree in Ecology and Soil Science from Dnipropetrovsk National University.
Ventana Medical Systems
Ventana Medical Systems, Inc., a member of the Roche Group, innovates and manufactures instruments and reagents that automate tissue processing and slide staining for cancer diagnostics. VENTANA solutions are used in clinical histology and drug development research laboratories worldwide. The company’s intuitive, integrated staining and workflow management platforms that optimize laboratory efficiencies to reduce errors – support diagnosis and inform treatment decisions for anatomic pathology professionals. Together with Roche, Ventana is driving personalized healthcare through accelerated drug discovery and the development of “companion diagnostics” to identify the patients most likely to respond favorably to specific therapies. Visit www.ventana.com to learn more.